chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 3/1/21 I received my first Moderna vaccine.  On 4/5/21 I had pain in my left leg and foot.  I was sent via ambulance to General Hospital and was diagnosed with a blocked popliteal artery.  The blockage was removed through the artery in my groin.  I was told at the time that the blockage was most likely due to a 2cm aneurysm behind my knee.  I was told that it was not related to the vaccine.  I was told that I should either have a bypass or a stent to correct the aneurysm.  I have since received 2 stents that have completely blocked and I have about 40% of normal blood flow to my lower leg.   I am now permanently disabled due to nerve and circulation issues my leg.  The initial blockage was most likely not due to the small aneurysm, but the thickening of the blood caused by the vaccine.
SEVERE INSOMNIA AFTER TAKING THE VACCINE. INABILITY TO FALL ASLEEP. INABILITY TO STAY ASLEEP
PATIENT REFERS FEELING NAUSEATED (FEELING SICK). WAS OBSERVED.
She fainted, and then immediately regained consciousness. She appeared pale, felt mildly weak and was teary after the event. She sat in my office and had a soda and granola bar. After about 15 minutes she regained her color felt better and went back to class. I attempted to notify parent but she was unavailable by phone, so I will continue to try. Note sent with student describing event.
-Swollen lympnodes in armpit of left arm (injected arm) starting 11/24 -Pain in spleen in upper left abdomen starting 11/25 -Pain in left arm at injection site
Swelling, itching, redness from elbow to shoulder. Hives and itching on back of neck and lower scalp.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included TRIAMCINOLONE ACETONIDE from 25-Oct-2021 to an unknown date, MUPIROCIN from 25-Oct-2021 to an unknown date and IBUPROFEN from 25-Oct-2021 to 25-Oct-2021 for an unknown indication.    On 25-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 25-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-413222 (Patient Link).
needed to re take second dose as punctured vial was open for more than six hours; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (The patient did not have any chronic or long standing health conditions.).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours). On 17-Feb-2021 at 6:00 PM, EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (needed to re take second dose as punctured vial was open for more than six hours) to be not applicable.    The patient did not take any concomitant medication.  The patient did not experience any adverse event.   This case was linked to MOD-2021-015145, MOD-2021-075375, MOD-2021-075421, MOD-2021-075507 (Patient Link).
Palpitations 6 weeks after vaccination, resolved; then shortness of breath at rest and with exercise, fatigue, beginning approximately 100 days after vaccination.  Diagnosed with congestive heart failure.  Already on anti-arrythmics, antihyperlipidemics, begun on lisinopril, lasix, and appointment made with cardiologist on 08/11/03 for echocardiogram  Follow up 02/08/2005: Final diagnosis "palpitations without documented dysrhythmia; shortness of breath and prior history of premature ventricular contractions and shortness of breath. 01/04 Persistent symptoms of shortness of breath, palpitations and edema.
Swelling and pain at the injection site... Lethargic, dizziness, headache
Pain in armpit, on same arm vaccine was administered in. It hurt/ached for about 5 days and then went away.  I assumed it was a swollen lymph node, as I had read that could be a symptom of the vaccine.
Subsequent to receiving one dose of varicella virus vaccine live the pt broke out in a mild case of chickenpox.
The day after the shot, my arm, neck and face had a severe rash.  I contacted my doctor and was advised that they never heard of  a rash on the face from the shot.  The rash did not go away, so I contacted my dermatologist.  She prescribed ointments to place on my face and other affected areas.   I then saw my doctor for my yearly and she advised prednisone may help knock it out.  My face got better, but the rash has spread to the rest of my body.  Looking at research papers, I believe I may have pityriasia rosea.   We are going on vacation  and I advised my doctors that I would reach out after April 11th if the rash is still there.    I am using triamcinolone acetonide 1% topical cream for my body & Hydrocortisone 2.5% ointment on my face.  1 week and then  use Tacrolimus Ointment .1%.  I typically get eczema on my elbows in the winter , helped with  cortisone cream.
Reddish, hot rash, itchy, sore, and firm skin all around and below the injection site.  Appeared after about one day, and worsened over the next two days.  Treating with rest and ice.  Soreness has subsided, but skin is still sensitive, warm, and rash has grown slightly
30 reddened pustules noted on trunk 3/14/04 afebrile, c/o slight sore throat. Dx atypical chickenpox lesions. Sibling similar symptoms 2 weeks ago. Mother similar symptoms 2 weeks prior to that.
This spontaneous report as received from an office supervisor  medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapies were not reported. On unknown date in 2017, the patient was vaccinated with an incorrect storage dose of GARDASIL 9 (lot # M036059 with expiration date of 03-JUN-2019; strength, dose, route and anatomical location were not provided), for prophylaxis. The vaccine was exposed from 47 degrees Fahrenheit to 77 degrees Fahrenheit for 12 hours. There was no previous temperature excursion. The call was made because there was a "data logger". No adverse effects were reported. No product quality complain was involved. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1707USA008817: US-009507513-1707USA008818: US-009507513-1707USA008819: US-009507513-1707USA008862: US-009507513-1707USA008863: US-009507513-1707USA008793: US-009507513-1707USA008820: US-009507513-1707USA008821: US-009507513-1707USA008839: US-009507513-1707USA008864: US-009507513-1707USA008865: US-009507513-1707USA008794: US-009507513-1707USA008822: US-009507513-1707USA008823: US-009507513-1707USA008840: US-009507513-1707USA008866: US-009507513-1707USA008867: US-009507513-1707USA008795: US-009507513-1707USA008824: US-009507513-1707USA008825: US-009507513-1707USA008841: US-009507513-1707USA008868: US-009507513-1707USA008869: US-009507513-1707USA008796: US-009507513-1707USA008826: US-009507513-1707USA008827: US-009507513-1707USA008828: US-009507513-1707USA008842: US-009507513-1707USA008870: US-009507513-1707USA008797: US-009507513-1707USA008829: US-009507513-1707USA008830: US-009507513-1707USA008843: US-009507513-1707USA008798: US-009507513-1707USA006643: US-009507513-1707USA008831: US-009507513-1707USA008832: US-009507513-1707USA008844: US-009507513-1707USA008845: US-009507513-1707USA008800: US-009507513-1707USA008833: US-009507513-1707USA008801: US-009507513-1707USA008802: US-009507513-1707USA008834: US-009507513-1707USA008846: US-009507513-1707USA008803: US-009507513-1707USA008804: US-009507513-1707USA008835: US-009507513-1707USA008847: US-009507513-1707USA008848: US-009507513-1707USA008805: US-009507513-1707USA008806: US-009507513-1707USA008849: US-009507513-1707USA008850: US-009507513-1707USA008807: US-009507513-1707USA008808: US-009507513-1707USA008851: US-009507513-1707USA008852: US-009507513-1707USA008853: US-009507513-1707USA008789: US-009507513-1707USA008809: US-009507513-1707USA008810: US-009507513-1707USA008854: US-009507513-1707USA008855: US-009507513-1707USA008790: US-009507513-1707USA008811: US-009507513-1707USA008812: US-009507513-1707USA008836: US-009507513-1707USA008856.
I had my vaccination on 04/08/2022. I started to experience diarrhea almost immediately and it lasted for months. I contacted my physician and they referred me to a gastroenterologist. In 2022 I was given a fat and fecal test which determined I have Exocrine Pancreatic Insufficiency. I have changed my diet and with medication I am feeling better on 04/10/2023. I am still having follow up appointments with my gastroenterologist to monitor my diagnosis.
Started a large red slightly raised rash on my right arm around the injection.  Started off as a rounded triangle and then started spreading downward and around back of my arm.  At times it was slightly itchy, and it was hard to the touch but for the most part it did not bother me at all.  Sometimes during the day it would look better then get more red and raised as the day went on.  By the 4th day it looks like it?s starting to go away although it?s still a little pink.
Severe headache. Swelling at injection site. Fever. Joint aches. Fatigue. Inability to concentrate. Dizziness. Triggered migraine headache with visual and auditory aura.
A couple days after taking the vaccine she started nothing something in her left eye.  She stated it was almost like floating dots.  Start experiencing problems in her left ankle.
Patient informed nurse that she felt like "everything is moving" that she is "very anxious and thirsty". Patient's BP was 145/99 and her Pulse was 128.
Has large local reaction, on right with pain on compression. Seen 11-11-09, rt deltoid with slight hematoma-pain variable on touch. No abscess or nodule noted.
Information has been received from a physician concerning an 8 week male who was vaccinated with Rotateq. Subsequently, the patient experienced abdominal pain, cramping and diarrhea for one or two weeks following his two month vaccine dose of Rotateq. The child did not die and needed no medical intervention. Additional information has been requested.
Report HA, nausea and body aches began next day post vaccination. Treatment: BC powder Outcome: Symptoms of nausea and body aches has improved. HA  remains unchanged. Does not interfere with ADLs.
Lot numbers not available on patient's chart. Stomach aches, fatigue, headache, sore throat due to coughing starting on 10/30/21
patient noted TDAP reaction (hives) in the past, after vaccine reported throat tightness and chest heaviness, EMS evaluation completed, given benadryl and alleviated and patient self drove himself home.
This case was considered medically important (OMIC). Info regarding Prevnar was received from a public health nurse regarding a male pt who on 10/08/04, at 12 months of age, received a dose of Prevnar. On 5/31/05, at 19 months of age, the pt developed pneumococcal bacteremia. Indication for Prevnar was immunization. Product was administered on 10/8/04. Dose regimen was 1 dose 1 time per day. Event Details: On 10/8/04, at 12 months of age, the pt received a dose of Prevnar. On 5/21/05, at 19 months of age, the child developed pneumococcal bacteremia (drug ineffective), after a blood culture performed on an unspecified date in 5/05, was positive for Streptococcus pneumoniae. The pt's recovery status is unknown. No additional info was available at the time of this report.
fainted and fell about a minute after the vaccine.  She was conscious about 30 seconds after fainting.  laid patient on the floor and elevated legs.  paramedics were callled, they took her BP and transported to Clinic for a check up.  Called patient tomorrow, and patient was okay.
With this being my daughters first shots I did not give her Tylenol prior to rec' her vaccination as I did not want to mask her reactions. Shortly after rec' the shot her leg was swollen, hot, red and tender to touch. Her temp began to rise. She was unable to sleep or rest due to the pain and was crying uncontrollably. I then decided it was best to give her Tylenol and her fever normalized and she was able to rest. Also did not nurse much or well.
loss of balance; Staggering; This is a spontaneous report from Pfizer-sponsored program. This is a report from contactable consumer or other non health professional (patient). A 80-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection; Batch/Lot Number: EP6955) via an unspecified route of administration, administered in Arm Right on 31Mar2021 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included ongoing blood cholesterol increased from 2009, ongoing macular degeneration, ongoing osteoporosis and high cholesterol. Concomitant medication(s) included ongoing calcium (CALCIUM) taken for osteoporosis and has been taking longer than 2016. Stated she takes calcium 1500 mg daily and the calcium was 600 mg and she takes 2.5 tablets; ongoing levothyroxine (LEVOTHYROXINE) taken at dose of 50 mg once a day for an unspecified indication from an unspecified start date; ongoing lovastatin (LOVASTATIN) taken at dose of 40 mg at bedtime for blood cholesterol increase from 2011; ongoing vitamin d3 (VITAMIN D3, Batch/Lot Number: EP6955) 500 units daily, for an unspecified indication from 2016; ongoing Areds 2 Eye Vitamin at dose of 2 every day,  she has been taking 8 years. Stated she was told she has macular degeneration then told she does not. Stated she was prescribed this in error and had just continued to take it. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection; Lot Number : EN62(or 7)05) via an unspecified route of administration, administered in Arm left on 10Mar2021 at 09:00 or 10:00  as 1st dose, single dose for covid-19 immunisation. Family Medical History Relevant medical history to AE none. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine was none. On an unspecified date the patient experienced loss of balance. She was unsure of exact date that it began. Stated she wasn't sure at first and was staggering and has to hold onto rails when she goes up steps. Stated it's all day. Stated she hadn't reported it because she thought it would clear up. she stated it had improved, but was still continuing. Caller added she was a very active person so she just didn't associate it with anything other than her age, when it first started she just felt like it was her age, then she calculated that it started soon after the shot, and confirms it was after the second shot. The outcome for the event Loss of balance was recovering and Staggering was unknown.
1 of 8 pt (4-6 yr old range) seen /win the past wk /w severe local rxns, pt had 3 X 2 inch area of redness, tenderness, warmth & low fever.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 2017 the patient was vaccinated with GARDASIL 9 lot # M036059 for prophylaxis. On 2017 the patient experienced incorrect product storage. The vaccine was exposed from 47°F to 77°F for 12 hours. On an unknown date the patient experienced no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered no adverse event and incorrect product storage to be not related to GARDASIL 9. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1707USA006643.
Covid arm; it was like a kick in the gutt; rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), DEPRESSED MOOD (it was like a kick in the gutt) and RASH (rash) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Covid arm), DEPRESSED MOOD (it was like a kick in the gutt) and RASH (rash). At the time of the report, VACCINATION SITE REACTION (Covid arm), DEPRESSED MOOD (it was like a kick in the gutt) and RASH (rash) outcome was unknown.            No Concomitant product use was reported.  The patient got Moderna as a booster, it was fine and then got a Covid arm and a rash. The patient felt like a kick in the gut.  No treatment information was provided.
She states that there was no further adverse event.; A patient was given expired VAQTA; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 22-APR-2021, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA)(strength, route, dose, frequency, and atomical location were unknown) with lot # T014590, and expiration date 15-APR-2021, for prophylaxis. The hepatitis a vaccine, inactivated(VAQTA) vaccine had not had any temperature excursions. The reporter stated that there was no further adverse event. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck; devicelotnumber: T014590; expirationdate: 15-APR-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Information has been received from a registered nurse concerning a 24 year old male, with no medical history or allergies, who was vaccinated with a first dose of MMR II, in 1984 and 1991 respectively. There were no concomitant medications. Subsequently, the patient had not seroconverted for mumps antibody. Lab diagnostic studies performed: antibody testing for measles, mumps and rubella. It was reported that the nurse "will administer another dose of MMR II". There was no product quality complaint involved. On 02-APR-2007 the patient experienced malabsorption. Additional information has been requested.
Fever that peaks quickly over 102 degrees, major chills, cough, sever weakness and fatigue, sever dizziness, lack of appetite, unstable body temperature; goes from sweating to feeling of freezing.
11/10/06  RECEIVED PHONE CALL FROM PATIENT REPORTS REDNESS,TENDERNESS, AT INJECTION SITE  WILL OBSERVE FOR NOW AND CALL WITH UPDATE 11/13/06.   REPORTS SITE IMPROVED.
On 04/17/01 at 8:30 PM, the mother noted a temp of 100.5, at 9:15 PM seizure one, time and vomiting twice. On 04/18/01 at 4:00 AM, patient had a temp of 103.9, difficulty breathing; resolved with nebulizer treatment. T 8:30 AM, the patient was seen in the clinic with a temp of 101. On 04/20/01, the patient had a recheck in the clinic, the temp was elevated to 103 on 04/19; no seizure. The patient was referred for a neuro work up.
NDC# 59267-1055-04  - lot # FL2757 with manufacturer's expiration date of Sept 30, 22. Information has been received from the manufacturer indicating that stability and efficacy data supports the use of this product through Oct.19, 2022.
Injection site reaction (70mm X 40mm of induration). Characterized by local errythma and moderate puritis - resolved in 10 days with OTC topical medication.
SORE ARM; FELT ILL; FEVERISH; This spontaneous report received from a patient concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case No concomitant medications were reported. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm, felt ill, and feverish. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, and the outcome of feverish and felt ill was not reported. This report was non-serious.